These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
325 related articles for article (PubMed ID: 6376863)
21. Renin-angiotensin-aldosterone system in arterial hypertension. Horký K; Gregorová I Cor Vasa; 1980; 22(1-2):59-73. PubMed ID: 6995018 [TBL] [Abstract][Full Text] [Related]
22. The effects of saralasin, an angiotensin II antagonist, on blood pressure and the renin-angiotensin-aldosterone system in normal and hypertensive subjects. Brown JJ; Brown WC; Fraser R; Lever AF; Morton JJ; Robertson JI; Rosei EA; Trust PM Aust N Z J Med; 1976 Aug; 6(3 Suppl):48-52. PubMed ID: 1071403 [TBL] [Abstract][Full Text] [Related]
23. Relationship between plasma catecholamines and the renin-aldosterone system during exercise in normal and essential hypertensive subjects. Jindra A; Savliková J; Bultas J Clin Exp Hypertens A; 1990; 12(3):415-35. PubMed ID: 2192824 [TBL] [Abstract][Full Text] [Related]
24. [Differences of blood plasma renin activity, angiotensin II and aldosterone levels in essential or secondary hypertension]. Song AL; Zeng ZP; Tong AL; Lu L; Chen S; Li M; Fu CL; Wang YH; Sun ML Zhonghua Nei Ke Za Zhi; 2012 Apr; 51(4):294-8. PubMed ID: 22781950 [TBL] [Abstract][Full Text] [Related]
25. An abnormal sodium metabolism in Japanese patients with essential hypertension, judged by serum sodium distribution, renal function and the renin-aldosterone system. Komiya I; Yamada T; Takasu N; Asawa T; Akamine H; Yagi N; Nagasawa Y; Ohtsuka H; Miyahara Y; Sakai H; Sato A; Aizawa T J Hypertens; 1997 Jan; 15(1):65-72. PubMed ID: 9050972 [TBL] [Abstract][Full Text] [Related]
26. [Studies on abnormalities of adrenal steroidogenesis in essential hypertension, primary aldosteronism and renovascular hypertension: responses of plasma steroids to angiotensin III]. Itoh N Nihon Naibunpi Gakkai Zasshi; 1988 May; 64(5):419-38. PubMed ID: 3410145 [TBL] [Abstract][Full Text] [Related]
27. [Clinical significance of serum angiotensin I-converting enzyme in essential hypertension]. Gotoh M Nihon Naibunpi Gakkai Zasshi; 1985 Dec; 61(12):1341-57. PubMed ID: 3005063 [TBL] [Abstract][Full Text] [Related]
28. [The significance of atrial natriuretic polypeptide in the cause of essential hypertension]. Mori K Nihon Naibunpi Gakkai Zasshi; 1991 Jul; 67(7):796-810. PubMed ID: 1653713 [TBL] [Abstract][Full Text] [Related]
29. [Significance of oxytocin to disorders of fluid and electrolyte metabolism in patients with essential hypertension]. Ono Y Nihon Naibunpi Gakkai Zasshi; 1987 Feb; 63(2):143-63. PubMed ID: 3569605 [TBL] [Abstract][Full Text] [Related]
30. Beta-adrenergic receptor blockade as a therapeutic approach for suppressing the renin-angiotensin-aldosterone system in normotensive and hypertensive subjects. Blumenfeld JD; Sealey JE; Mann SJ; Bragat A; Marion R; Pecker MS; Sotelo J; August P; Pickering TG; Laragh JH Am J Hypertens; 1999 May; 12(5):451-9. PubMed ID: 10342782 [TBL] [Abstract][Full Text] [Related]
31. [Renin aldosterone profile in essential hypertension during pregnancy and after delivery]. Niegowska J; Sitkiewicz D Pol Arch Med Wewn; 2004 May; 111(5):547-56. PubMed ID: 15508805 [TBL] [Abstract][Full Text] [Related]
32. Response of plasma renin-angiotensin system to a single captopril administration in patients receiving long-term treatment with captopril. Iwata T; Dazai Y; Kitami Y; Muneta S; Imamura Y; Murakami E; Hiwada K Clin Exp Pharmacol Physiol; 1992 Oct; 19(10):705-9. PubMed ID: 1424299 [TBL] [Abstract][Full Text] [Related]
33. Comparisons of body fluid volumes, plasma renin activity, hemodynamics and pressor responsiveness between juvenile and aged patients with essential hypertension. Ishii M; Ohno K Jpn Circ J; 1977 Mar; 41(3):237-46. PubMed ID: 870721 [TBL] [Abstract][Full Text] [Related]
34. The state and responsiveness of the renin-angiotensin-aldosterone system in patients with type II diabetes mellitus. Price DA; De'Oliveira JM; Fisher ND; Williams GH; Hollenberg NK Am J Hypertens; 1999 Apr; 12(4 Pt 1):348-55. PubMed ID: 10232494 [TBL] [Abstract][Full Text] [Related]
35. Effects of losartan on the renin-angiotensin-aldosterone axis in essential hypertension. Bauer IH; Reams GP; Wu Z; Lau-Sieckman A J Hum Hypertens; 1995 Apr; 9(4):237-43. PubMed ID: 7595905 [TBL] [Abstract][Full Text] [Related]
36. Plasma renin activity and aldosterone concentrations in hypertensive cats with and without azotemia and in response to treatment with amlodipine besylate. Jepson RE; Syme HM; Elliott J J Vet Intern Med; 2014; 28(1):144-53. PubMed ID: 24428319 [TBL] [Abstract][Full Text] [Related]
37. Attenuation of angiotensin II- and III-induced aldosterone release by prostaglandin synthesis inhibitors. Campbell WB; Gomez-Sanchez CE; Adams BV; Schmitz JM; Itskovitz HD J Clin Invest; 1979 Dec; 64(6):1552-7. PubMed ID: 500824 [TBL] [Abstract][Full Text] [Related]
38. The effect of an angiotensin antagonist (saralasin) on arterial pressure and plasma aldosterone in hemodialysis-resistant hypertensive patients. Mimran A; Shaldon S; Barjon P; Mion C Clin Nephrol; 1978 Feb; 9(2):63-7. PubMed ID: 639368 [TBL] [Abstract][Full Text] [Related]
39. Normokalemic hyperaldosteronism in patients with resistant hypertension. Benchetrit S; Bernheim J; Podjarny E Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302 [TBL] [Abstract][Full Text] [Related]
40. Renin-angiotensin-aldosterone system of the normothermic marmot. Kastner PR; Zatzman ML; South FE; Johnson JA Am J Physiol; 1977 Jul; 233(1):R37-43. PubMed ID: 195479 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]